GlassScriptPhysician profile
Daniel J Gross
NPI 1184035552
$23,867.15
in general payments reported to CMS, 2019-2025
15 companies · $5,542 in 2025
The $5,542 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $759 · 2023: $9,580 · 2024: $7,985 · 2025: $5,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $15K · Travel and Lodging: $6,566 · Food and Beverage: $1,883 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14,500.00 |
| Travel and Lodging | $6,566.45 |
| Food and Beverage | $1,882.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,359.12 | 2023-2025 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Medical Device Business Services, INC. | $815.39 | 2023 | Matrixrib |
| Boston Scientific Corporation | $659.78 | 2021-2023 | Exalt Model D |
| Depuy Synthes Sales INC. | $257.30 | 2023-2025 | Matrixrib, Na |
| Bolton Medical INC | $161.67 | 2023 | Treo Abdominal Stent-Graft System |
| Baxter Healthcare | $149.74 | 2021-2025 | Tisseel |
| Tela Bio, INC. | $115.77 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Astrazeneca Pharmaceuticals LP | $94.83 | 2025 | Imfinzi |
| Erbe USA INC | $75.00 | 2024 | Vio 3 Cryo2 |
| Innovation Technologies INC | $45.03 | 2024 | Irrisept |
| Access Pro Medical, LLC | $30.62 | 2025 | Matriderm |
| Medtronic, INC. | $29.99 | 2025 | Endoflip |
| Grifols USA, LLC | $27.73 | 2025 | Thrombate III |
| Solventum Corporation | $26.35 | 2025 | Prevena, Abthera, Activ.A.C. |
| Dilon Technologies, INC. | $18.83 | 2025 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.